New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases
New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases
复制标题
DOI:
10.1161/strokeaha.116.012888
复制
发表时间:
2017-02-01
期刊:
影响因子:
8.3
通讯作者:
Schwaninger, Markus
中科院分区:
文献类型:
--
作者:
Mueller, Kristin;Courtois, Gilles;Schwaninger, Markus
Müller et al Pathogenesis of Cerebral Small-Vessel Diseases 521 in the extracellular domain of NOTCH3 (N3ECD) and lead to the extracellular accumulation of granular osmiophilic material containing N3ECD. 16 The mutated N3ECD seems to gain a toxic protein function (see below). Postmortem studies have shown a loss of vascular smooth muscle cells, thickening of the vessel wall, and luminal stenosis of arterioles. 16 At the capillary level, a loss of endothelial cells and pericytes has been reported (Figure 1). 18 Preclinical studies provide good evidence that pericytes stabilize the BBB. 19 Thus, the loss of pericytes may explain the disruption of the BBB that has been described in case reports and in a mouse model of the disease. 20, 21 Between and even within families, the clinical picture is heterogeneous, 22 but 4 major symptoms are present in most CADASIL patients, ie, recurrent subcortical ischemic attacks, migraine with aura, cognitive decline, and mood disorders. Almost 85% of patients have transient ischemic attacks or lacunar ischemic strokes with a mean onset in the fifth or sixth decade. 22, 23 Migraine with aura affects one fifth to two thirds of patients and is at least 5× more frequent than in the general population. 22, 23 After and sometimes even before transient ischemic attacks and stroke occur, some patients have impaired memory. 16 Among psychiatric manifestations, depression and apathy are most common. 23 To date, genetic testing serves as the gold standard for diagnosing this disease, and only symptomatic treatment is available. 23